# PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

> **NCT05806853** · PHASE2 · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 60 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga-PSMA
- **DRUG:** 68Ga-RM2

## Key facts

- **NCT ID:** NCT05806853
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-03
- **Primary completion:** 2022-10-05
- **Final completion:** 2022-10-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05806853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05806853, "PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05806853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*